SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-14-034117
Filing Date
2014-05-02
Accepted
2014-05-02 16:23:16
Documents
5
Effectiveness Date
2014-05-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A a14-11440_3defa14a.htm DEFA14A 34578
2 GRAPHIC g114403bci001.gif GRAPHIC 51403
3 GRAPHIC g114403bci002.gif GRAPHIC 79730
4 GRAPHIC g114403bci003.gif GRAPHIC 16387
5 GRAPHIC g114403bci004.gif GRAPHIC 3889
  Complete submission text file 0001104659-14-034117.txt   244773
Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36065 | Film No.: 14809690
SIC: 2836 Biological Products, (No Diagnostic Substances)